Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Quinine – QT prolongation risk & interactions

Posted on:

Despite repeated warnings about an unfavourable balance between risks and benefits, prescribing of quinine salts in NECS stakeholder CCGs has remained remarkably constant in recent years.

The MHRA have issued a reminder about the potential for quinine to effect the QT interval,  along with updated information about interactions – particularly with anticonvulsant drugs.

Advice for healthcare professionals:

  • be aware of dose-dependent effects on the QT interval and use caution if prescribing quinine in patients:
    • with conditions that predispose to QT prolongation such as pre-existing cardiac disease or electrolyte disturbance
    • taking other medicines that could prolong the QT interval
    • with atrioventricular block
  • monitor patients closely if administration of quinine with phenobarbital or carbamazepine is necessary; serum levels of these anticonvulsant medicines could become raised and cause anticonvulsant toxicity
  • consult the Summary of Product Characteristics for a full list of interacting medicines and potential adverse reactions
  • report suspected adverse drug reactions with quinine on a Yellow Card